TILT Biotherapeutics Signs a Licensing Deal with Biotheus for Cancer Therapy with Oncolytic Virus TILT-123 Read more
Roche submits sBLA to the FDA for Tecentriq in combination with Avastin for the most common form of liver cancer Read more
FDA Approves Merck’s DIFICID (fidaxomicin) to Treat Clostridioides difficile in Children Aged Six Months and Older Read more
Bionetix, ProQinase, and MercachemSyncom Announce a Joint Research Project from Target Identification to Clinical Study Read more
Join experts within supply and demand at Europe’s Only Parallel Trade Conference 2020 in London Read more